SCHEMBL13675199

SCHEMBL13675199

Cc1nc2ncnc(C)c2s1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM4 P08173 1/20 0.39
HSD17B10 Q99714 4/20 0.34
KDM4E B2RXH2 2/20 0.34
MAPK1 P28482 1/20 0.34
CDC7 O00311 5/20 0.34
DBF4 Q9UBU7 5/20 0.34
NPC1 O15118 3/20 0.31
ALDH1A1 P00352 2/20 0.31
MAPT P10636 2/20 0.31
HPGD P15428 2/20 0.31
RAB9A P51151 2/20 0.31
TP53 P04637 1/20 0.31
PKM P14618 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
USP2 O75604 2/20 0.31
CDK2 P24941 2/20 0.30
PLK4 O00444 1/20 0.30
IKBKB O14920 1/20 0.30
AURKA O14965 1/20 0.30
CHUK O15111 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20752274 0.76 KDR (0.42) CHRM4HSD17B10KDM4ECDC7DBF4
SCHEMBL14461575 0.75 KDM4E (0.33) HSD17B10KDM4EMAPK1
SCHEMBL12292761 0.68
SCHEMBL10200849 0.68 LTA4H (0.41) CHRM4HSD17B10KDM4EMAPK1NPC1
SCHEMBL4403923 0.67 KDM4E (0.38) CHRM4KDM4EALDH1A1PKM
SCHEMBL19626329 0.67 KDR (0.36) KDR
SCHEMBL17339846 0.66 HSD17B10 (0.33) HSD17B10KDM4EMAPK1NPC1ALDH1A1
SCHEMBL14959701 0.65 CHRM4 (0.39) CHRM4HSD17B10KDM4EMAPK1CDC7
SCHEMBL21621605 0.64 RAB9A (0.47) HSD17B10KDM4EMAPK1NPC1ALDH1A1
SCHEMBL813862 0.64 SMN1; SMN2 (0.39) HSD17B10KDM4ENPC1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021126995-A1 METHODS AND COMPOSITIONS FOR TREATING CANCER ENGINE BIOSCIENCES PTE. LTD. (SG) 2021-06-24 WO disclosed
US-7605154-B2 ATP-protein kinase inhibitors; cytomegalovirus; contraceptive agents; cancer; N7-(3-ethynyl-phenyl)-N2-(4-piperidin-1-ylmethyl-phenyl)-thiazolo[4,5-d]pyrimidine-2,7-diamine JANSSEN PHARMACEUTICA N.V. (BE) 2009-10-20 US disclosed